WileyPlus: Tamarisk Corporation's post-closing trial balance at December 31, 2025, is as follows.

TAMARISK CORPORATION

Post-Closing Trial Balance

December 31, 2025

Dr.

Cr.

Accounts payable

$307,700

Accounts receivable

$492,000

Accumulated depreciation -buildings

189,000

Additional paid-in capital in excess

of par-common

1,386,000

From treasury stock

161,000

Allowance for doubtful accounts

29,000

Bonds payable

319,000

Buildings

1,496,000

Cash

188,000

Common stock ($1 par)

202,000

Dividends payable (preferred stock-cash)

4,300

Inventory

609,000

Land

380,000

Preferred stock ($50 par)

450,000

Prepaid expenses

36,000

Retained earnings

319,000

Treasury stock (common at cost)

166,000

Totals

$3,367.000

$3.367.000

At December 31, 2025, Tamarisk had the following number of common and preferred shares.

Common

Preferred

Authorized

606,000

54,000

Issued

202,000

9.000

Outstanding

197,000

9.000

The dividends on preferred stock are $4 cumulative. In addition, the preferred stock has a preference in liquidation of $50 per share.

Prepare the stockholders' equity section of Tamarisk's balance sheet at December 31, 2025.